Dexlansoprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach. Dexlansoprazole is used to treat heartburn caused by gastroesophageal reflux disease (GERD), and to heal erosive esophagitis (damage to the esophagus from stomach acid).

The global Dexlansoprazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Dexlansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Dexlansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Dexlansoprazole include Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical and Sailong, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Dexlansoprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dexlansoprazole.

Report Scope

The Dexlansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dexlansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dexlansoprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Dexlansoprazole Market Report

Report Metric	Details
Report Name	Dexlansoprazole Market
Segment by Type	30 mg 60 mg
Segment by Application	Gastroesophageal Reflux Disease Heal Erosive Esophagitis
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical, Sailong
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dexlansoprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dexlansoprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dexlansoprazole Market report?

Ans: The main players in the Dexlansoprazole Market are Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical, Sailong

What are the Application segmentation covered in the Dexlansoprazole Market report?

Ans: The Applications covered in the Dexlansoprazole Market report are Gastroesophageal Reflux Disease, Heal Erosive Esophagitis

What are the Type segmentation covered in the Dexlansoprazole Market report?

Ans: The Types covered in the Dexlansoprazole Market report are 30 mg, 60 mg

1 Dexlansoprazole Market Overview

1.1 Product Overview and Scope of Dexlansoprazole

1.2 Dexlansoprazole Segment by Type

1.2.1 Global Dexlansoprazole Market Value Comparison by Type (2024-2030)

1.2.2 30 mg

1.2.3 60 mg

1.3 Dexlansoprazole Segment by Application

1.3.1 Global Dexlansoprazole Market Value by Application: (2024-2030)

1.3.2 Gastroesophageal Reflux Disease

1.3.3 Heal Erosive Esophagitis

1.4 Global Dexlansoprazole Market Size Estimates and Forecasts

1.4.1 Global Dexlansoprazole Revenue 2019-2030

1.4.2 Global Dexlansoprazole Sales 2019-2030

1.4.3 Global Dexlansoprazole Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Dexlansoprazole Market Competition by Manufacturers

2.1 Global Dexlansoprazole Sales Market Share by Manufacturers (2019-2024)

2.2 Global Dexlansoprazole Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Dexlansoprazole Average Price by Manufacturers (2019-2024)

2.4 Global Dexlansoprazole Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Dexlansoprazole, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Dexlansoprazole, Product Type & Application

2.7 Dexlansoprazole Market Competitive Situation and Trends

2.7.1 Dexlansoprazole Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Dexlansoprazole Players Market Share by Revenue

2.7.3 Global Dexlansoprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Dexlansoprazole Retrospective Market Scenario by Region

3.1 Global Dexlansoprazole Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Dexlansoprazole Global Dexlansoprazole Sales by Region: 2019-2030

3.2.1 Global Dexlansoprazole Sales by Region: 2019-2024

3.2.2 Global Dexlansoprazole Sales by Region: 2025-2030

3.3 Global Dexlansoprazole Global Dexlansoprazole Revenue by Region: 2019-2030

3.3.1 Global Dexlansoprazole Revenue by Region: 2019-2024

3.3.2 Global Dexlansoprazole Revenue by Region: 2025-2030

3.4 North America Dexlansoprazole Market Facts & Figures by Country

3.4.1 North America Dexlansoprazole Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Dexlansoprazole Sales by Country (2019-2030)

3.4.3 North America Dexlansoprazole Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Dexlansoprazole Market Facts & Figures by Country

3.5.1 Europe Dexlansoprazole Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Dexlansoprazole Sales by Country (2019-2030)

3.5.3 Europe Dexlansoprazole Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Dexlansoprazole Market Facts & Figures by Country

3.6.1 Asia Pacific Dexlansoprazole Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Dexlansoprazole Sales by Country (2019-2030)

3.6.3 Asia Pacific Dexlansoprazole Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Dexlansoprazole Market Facts & Figures by Country

3.7.1 Latin America Dexlansoprazole Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Dexlansoprazole Sales by Country (2019-2030)

3.7.3 Latin America Dexlansoprazole Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Dexlansoprazole Market Facts & Figures by Country

3.8.1 Middle East and Africa Dexlansoprazole Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Dexlansoprazole Sales by Country (2019-2030)

3.8.3 Middle East and Africa Dexlansoprazole Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Dexlansoprazole Sales by Type (2019-2030)

4.1.1 Global Dexlansoprazole Sales by Type (2019-2024)

4.1.2 Global Dexlansoprazole Sales by Type (2025-2030)

4.1.3 Global Dexlansoprazole Sales Market Share by Type (2019-2030)

4.2 Global Dexlansoprazole Revenue by Type (2019-2030)

4.2.1 Global Dexlansoprazole Revenue by Type (2019-2024)

4.2.2 Global Dexlansoprazole Revenue by Type (2025-2030)

4.2.3 Global Dexlansoprazole Revenue Market Share by Type (2019-2030)

4.3 Global Dexlansoprazole Price by Type (2019-2030)

5 Segment by Application

5.1 Global Dexlansoprazole Sales by Application (2019-2030)

5.1.1 Global Dexlansoprazole Sales by Application (2019-2024)

5.1.2 Global Dexlansoprazole Sales by Application (2025-2030)

5.1.3 Global Dexlansoprazole Sales Market Share by Application (2019-2030)

5.2 Global Dexlansoprazole Revenue by Application (2019-2030)

5.2.1 Global Dexlansoprazole Revenue by Application (2019-2024)

5.2.2 Global Dexlansoprazole Revenue by Application (2025-2030)

5.2.3 Global Dexlansoprazole Revenue Market Share by Application (2019-2030)

5.3 Global Dexlansoprazole Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Takeda

6.1.1 Takeda Corporation Information

6.1.2 Takeda Description and Business Overview

6.1.3 Takeda Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Takeda Dexlansoprazole Product Portfolio

6.1.5 Takeda Recent Developments/Updates

6.2 Cardinal Health

6.2.1 Cardinal Health Corporation Information

6.2.2 Cardinal Health Description and Business Overview

6.2.3 Cardinal Health Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Cardinal Health Dexlansoprazole Product Portfolio

6.2.5 Cardinal Health Recent Developments/Updates

6.3 Suzhou Homesun Pharmaceutical

6.3.1 Suzhou Homesun Pharmaceutical Corporation Information

6.3.2 Suzhou Homesun Pharmaceutical Description and Business Overview

6.3.3 Suzhou Homesun Pharmaceutical Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Suzhou Homesun Pharmaceutical Dexlansoprazole Product Portfolio

6.3.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates

6.4 Frontida

6.4.1 Frontida Corporation Information

6.4.2 Frontida Description and Business Overview

6.4.3 Frontida Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Frontida Dexlansoprazole Product Portfolio

6.4.5 Frontida Recent Developments/Updates

6.5 Zhendong Group

6.5.1 Zhendong Group Corporation Information

6.5.2 Zhendong Group Description and Business Overview

6.5.3 Zhendong Group Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Zhendong Group Dexlansoprazole Product Portfolio

6.5.5 Zhendong Group Recent Developments/Updates

6.6 Ouya Pharmaceutical

6.6.1 Ouya Pharmaceutical Corporation Information

6.6.2 Ouya Pharmaceutical Description and Business Overview

6.6.3 Ouya Pharmaceutical Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Ouya Pharmaceutical Dexlansoprazole Product Portfolio

6.6.5 Ouya Pharmaceutical Recent Developments/Updates

6.7 Heron Pharmaceutical

6.6.1 Heron Pharmaceutical Corporation Information

6.6.2 Heron Pharmaceutical Description and Business Overview

6.6.3 Heron Pharmaceutical Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Heron Pharmaceutical Dexlansoprazole Product Portfolio

6.7.5 Heron Pharmaceutical Recent Developments/Updates

6.8 Sailong

6.8.1 Sailong Corporation Information

6.8.2 Sailong Description and Business Overview

6.8.3 Sailong Dexlansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Sailong Dexlansoprazole Product Portfolio

6.8.5 Sailong Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Dexlansoprazole Industry Chain Analysis

7.2 Dexlansoprazole Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Dexlansoprazole Production Mode & Process

7.4 Dexlansoprazole Sales and Marketing

7.4.1 Dexlansoprazole Sales Channels

7.4.2 Dexlansoprazole Distributors

7.5 Dexlansoprazole Customers

8 Dexlansoprazole Market Dynamics

8.1 Dexlansoprazole Industry Trends

8.2 Dexlansoprazole Market Drivers

8.3 Dexlansoprazole Market Challenges

8.4 Dexlansoprazole Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda

Cardinal Health

SUZHOU HOMESUN PHARMACEUTICAL

List of Tables

Table 1. Global Dexlansoprazole Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Dexlansoprazole Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Dexlansoprazole Market Competitive Situation by Manufacturers in 2023

Table 4. Global Dexlansoprazole Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Dexlansoprazole Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Dexlansoprazole Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Dexlansoprazole Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Dexlansoprazole Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Dexlansoprazole, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Dexlansoprazole, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Dexlansoprazole, Product Type & Application

Table 12. Global Key Manufacturers of Dexlansoprazole, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Dexlansoprazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dexlansoprazole as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Dexlansoprazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Dexlansoprazole Sales by Region (2019-2024) & (K Units)

Table 18. Global Dexlansoprazole Sales Market Share by Region (2019-2024)

Table 19. Global Dexlansoprazole Sales by Region (2025-2030) & (K Units)

Table 20. Global Dexlansoprazole Sales Market Share by Region (2025-2030)

Table 21. Global Dexlansoprazole Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Dexlansoprazole Revenue Market Share by Region (2019-2024)

Table 23. Global Dexlansoprazole Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Dexlansoprazole Revenue Market Share by Region (2025-2030)

Table 25. North America Dexlansoprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Dexlansoprazole Sales by Country (2019-2024) & (K Units)

Table 27. North America Dexlansoprazole Sales by Country (2025-2030) & (K Units)

Table 28. North America Dexlansoprazole Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Dexlansoprazole Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Dexlansoprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Dexlansoprazole Sales by Country (2019-2024) & (K Units)

Table 32. Europe Dexlansoprazole Sales by Country (2025-2030) & (K Units)

Table 33. Europe Dexlansoprazole Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Dexlansoprazole Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Dexlansoprazole Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Dexlansoprazole Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Dexlansoprazole Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Dexlansoprazole Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Dexlansoprazole Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Dexlansoprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Dexlansoprazole Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Dexlansoprazole Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Dexlansoprazole Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Dexlansoprazole Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Dexlansoprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Dexlansoprazole Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Dexlansoprazole Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Dexlansoprazole Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Dexlansoprazole Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Dexlansoprazole Sales (K Units) by Type (2019-2024)

Table 51. Global Dexlansoprazole Sales (K Units) by Type (2025-2030)

Table 52. Global Dexlansoprazole Sales Market Share by Type (2019-2024)

Table 53. Global Dexlansoprazole Sales Market Share by Type (2025-2030)

Table 54. Global Dexlansoprazole Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Dexlansoprazole Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Dexlansoprazole Revenue Market Share by Type (2019-2024)

Table 57. Global Dexlansoprazole Revenue Market Share by Type (2025-2030)

Table 58. Global Dexlansoprazole Price (US$/Unit) by Type (2019-2024)

Table 59. Global Dexlansoprazole Price (US$/Unit) by Type (2025-2030)

Table 60. Global Dexlansoprazole Sales (K Units) by Application (2019-2024)

Table 61. Global Dexlansoprazole Sales (K Units) by Application (2025-2030)

Table 62. Global Dexlansoprazole Sales Market Share by Application (2019-2024)

Table 63. Global Dexlansoprazole Sales Market Share by Application (2025-2030)

Table 64. Global Dexlansoprazole Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Dexlansoprazole Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Dexlansoprazole Revenue Market Share by Application (2019-2024)

Table 67. Global Dexlansoprazole Revenue Market Share by Application (2025-2030)

Table 68. Global Dexlansoprazole Price (US$/Unit) by Application (2019-2024)

Table 69. Global Dexlansoprazole Price (US$/Unit) by Application (2025-2030)

Table 70. Takeda Corporation Information

Table 71. Takeda Description and Business Overview

Table 72. Takeda Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Takeda Dexlansoprazole Product

Table 74. Takeda Recent Developments/Updates

Table 75. Cardinal Health Corporation Information

Table 76. Cardinal Health Description and Business Overview

Table 77. Cardinal Health Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Cardinal Health Dexlansoprazole Product

Table 79. Cardinal Health Recent Developments/Updates

Table 80. Suzhou Homesun Pharmaceutical Corporation Information

Table 81. Suzhou Homesun Pharmaceutical Description and Business Overview

Table 82. Suzhou Homesun Pharmaceutical Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Suzhou Homesun Pharmaceutical Dexlansoprazole Product

Table 84. Suzhou Homesun Pharmaceutical Recent Developments/Updates

Table 85. Frontida Corporation Information

Table 86. Frontida Description and Business Overview

Table 87. Frontida Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Frontida Dexlansoprazole Product

Table 89. Frontida Recent Developments/Updates

Table 90. Zhendong Group Corporation Information

Table 91. Zhendong Group Description and Business Overview

Table 92. Zhendong Group Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Zhendong Group Dexlansoprazole Product

Table 94. Zhendong Group Recent Developments/Updates

Table 95. Ouya Pharmaceutical Corporation Information

Table 96. Ouya Pharmaceutical Description and Business Overview

Table 97. Ouya Pharmaceutical Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Ouya Pharmaceutical Dexlansoprazole Product

Table 99. Ouya Pharmaceutical Recent Developments/Updates

Table 100. Heron Pharmaceutical Corporation Information

Table 101. Heron Pharmaceutical Description and Business Overview

Table 102. Heron Pharmaceutical Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Heron Pharmaceutical Dexlansoprazole Product

Table 104. Heron Pharmaceutical Recent Developments/Updates

Table 105. Sailong Corporation Information

Table 106. Sailong Description and Business Overview

Table 107. Sailong Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Sailong Dexlansoprazole Product

Table 109. Sailong Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Dexlansoprazole Distributors List

Table 113. Dexlansoprazole Customers List

Table 114. Dexlansoprazole Market Trends

Table 115. Dexlansoprazole Market Drivers

Table 116. Dexlansoprazole Market Challenges

Table 117. Dexlansoprazole Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Dexlansoprazole

Figure 2. Global Dexlansoprazole Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Dexlansoprazole Market Share by Type in 2023 & 2030

Figure 4. 30 mg Product Picture

Figure 5. 60 mg Product Picture

Figure 6. Global Dexlansoprazole Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Dexlansoprazole Market Share by Application in 2023 & 2030

Figure 8. Gastroesophageal Reflux Disease

Figure 9. Heal Erosive Esophagitis

Figure 10. Global Dexlansoprazole Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Dexlansoprazole Market Size (2019-2030) & (US$ Million)

Figure 12. Global Dexlansoprazole Sales (2019-2030) & (K Units)

Figure 13. Global Dexlansoprazole Average Price (US$/Unit) & (2019-2030)

Figure 14. Dexlansoprazole Report Years Considered

Figure 15. Dexlansoprazole Sales Share by Manufacturers in 2023

Figure 16. Global Dexlansoprazole Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Dexlansoprazole Players: Market Share by Revenue in 2023

Figure 18. Dexlansoprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Dexlansoprazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Dexlansoprazole Sales Market Share by Country (2019-2030)

Figure 21. North America Dexlansoprazole Revenue Market Share by Country (2019-2030)

Figure 22. U.S. Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Dexlansoprazole Sales Market Share by Country (2019-2030)

Figure 25. Europe Dexlansoprazole Revenue Market Share by Country (2019-2030)

Figure 26. Germany Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Dexlansoprazole Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Dexlansoprazole Revenue Market Share by Region (2019-2030)

Figure 33. China Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Taiwan Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Indonesia Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Thailand Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Malaysia Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Philippines Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Dexlansoprazole Sales Market Share by Country (2019-2030)

Figure 44. Latin America Dexlansoprazole Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Dexlansoprazole Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Dexlansoprazole Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Dexlansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Dexlansoprazole by Type (2019-2030)

Figure 54. Global Revenue Market Share of Dexlansoprazole by Type (2019-2030)

Figure 55. Global Dexlansoprazole Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of Dexlansoprazole by Application (2019-2030)

Figure 57. Global Revenue Market Share of Dexlansoprazole by Application (2019-2030)

Figure 58. Global Dexlansoprazole Price (US$/Unit) by Application (2019-2030)

Figure 59. Dexlansoprazole Value Chain

Figure 60. Dexlansoprazole Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions